The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Stockpick,
Might i remind you that you claimed that GDR was "running out of cash", without producing any specific figures or financial projections.
Yet again you have avoided my question - if you believe the company is about to run out of cash then please provide supportive evidence to back up this claim.
Whilst you haven't answered my question, i'll answer yours, even though i have told you this before:
I have a mixture of FTSE stocks, cash, Unit Trusts, rental properties, and AIM stocks - as part of a diverse and balanced portfolio of assets.
I realise AIM listed stocks are risky, but are a risk i am comfortable with.
I also believe significant revenue will be generated in the medium-long term future for the stroke and hearing loss products.
Kind Regards,
Stephen11.
Ps...another question - why are you so interested in a stock you are not invested in?
Classic case as of all talk and no substance.
Question below:
Let’s see your cash flow figures and projections then Stockpick?
Or else what are you basing your figures on cash flow around?
Speculation maybe 🤔??
Hope you and the good lady are keeping well.
There is a lot of misinformation on this board at present with regard to GDRs cash position/runway.
When your time permits could you repost your cash projection message.
Best Wishes,
Stephen11.
They certainly seem to be putting the products out there. That's about 5/6 conferences they've attended all around Europe in the last 2/3 weeks - hopefully sales start to follow - very soon!
Should also get NICE news in December 2023 regarding the stroke genotyping test .
See paragraph from RNS on 28th Sept 2023 below:
"The draft guidance from the UK's National Institute for Health and Care Excellence ("NICE") Diagnostics Assessment Programme "Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack" has recommended that CYP2C19 genotyping should be used before clopidogrel administration in the management of ischemic stroke patients. NICE's final report is now due in December 2023, and the Company is working to provide final performance specifications for the report. The work for DEVOTE will mostly contribute towards the extended clinical performance data now required for IVDR registration of new products in the EU."
GLA.
Stephen11.
James Cheek has previously worked for three of the worlds leading diagnostic companies. That is:
Cepheid - Revenue for 2022 - $4.3 Billion
Beckman Coulter - Revenue for 2022 - $4.7 Billion
Roache Diagnostics Division - Revenue for 2022 - $17.7 Billion
In roles within these companies he had extensive involvement in selling directly to the NHS. Additionally, his experience from being a Director of the British In Vitro Diagnostic Association (BIVDA) should prove invaluable, given this organisations close working relationships and previous collaborations with the NHS.
GLA.
Stephen11.
A big part of why i invested back in 2021 - as well as the lithium, of course!
I quote from a slide in a previous investormeetcompany presentation:
"Acquired the Fatou Gold project in Mali with immediate mineral resource potential exceeding 350,000oz Gold".
Great potential future value.
Todays UK Gold Price = £1, 590 per ounce!
As a conservative estimate, around £556 million worth of Gold in Fatou, waiting to be extracted.
GLA
Stephen11.
Ps...and that's only one of the gold resources.
A few posters have been asking about Kodal's gold resources - find one of two messages i have posted previously below:
In context - Kodal own gold resources that are approximately 3 times the size of the Isle of man!
Detailed breakdown below:
Names and numbers for the Gold concessions in Cote d'Ivoire and Corvette
Corvette:
PR-399 212 Km² (NIELLE)
PR400 396.761 Km² (M’BIHIAKRO)
PR-398 229.02 Km² (TIEBISSOU)
International Goldfields Cote d’Ivoire
PR0834 394.7647Km² (BOUNDIALI)
PR-427 200.4052Km² (KORHOGO)
PR-426 220.7688 Km² (DABAKALA)
Obviously, i would presume the gold will not be evenly distributed amongst this land and the ongoing testing will be needed to identify the best ground - but its vast!
GLA.
Stephen11.
Totally agree BigAl,
This board has been polluted with Walter Mitty style fantasists, proven liars, and non-shareholding fantasists for far to long. I find it peculiar why so many post on shares they are not invested in and appear to dislike so much.
I’ve that many green boxes now it looks like St. Patrick’s day ☘️.
Yes, it will be good to hear from the board and get a sight of the new CEO.
I’m still hoping for NICE news on the stroke product in Dec.
Hope your keeping well,
Stephen11.
Https://www.lse.co.uk/rns/GDR/
As above.
It will be good to see and hear James Cheek the new CEO.
GLA.
Stephen11.
It’s only Hainan’s Vice Chairman.
Shows how important Kodal is to Hainan.
First name David - didn’t catch his surname.
Further drilling to follow starting this month, to fast track development of the Bougouni area - fantastic.
Good news on multiple fronts.
Stephen11